Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

22 Aug 2007 12:46

Bespak PLC22 August 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer BESPAK PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) Both 3. Name of person discharging managerial responsibilities/director Mark Throdahl Director Paul Boughton Director Jon Glenn Director Joe Barry PDMR Keyvan Djamarani PDMR Chris Hall PDMR Kevin Burrow PDMR Jenny Owen Company Secretary 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person N/A 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest THE NOTIFICATION IS IN RESPECT OF HOLDINGS OF THE PERSONS REFERRED TO IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares N/A 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them N/A 8. State the nature of the transaction N/A 9. Number of shares, debentures or financial instruments relating to sharesacquired N/A 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A 11. Number of shares, debentures or financial instruments relating to sharesdisposed N/A 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A 13. Price per share or value of transaction N/A 14. Date and place of transaction N/A 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) N/A 16. N/A If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17. Date of grant 21 August 2007 18. Period during which or date on which it can be exercised 21 August 2010 provided the applicable performance criteria have been satisfied 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) Grant of Performance Shares and Share Appreciation Rights (SARS) under theBespak plc 2005 LTIP in respect of ordinary 10p shares as follows Name Status Performance SARS Shares Mark Throdahl Director 18,000 105,000Jonathan Glenn Director 23,500 NilPaul Boughton Director 25,000 NilChris Hall PDMR 6,500 22,750Joe Barry PDMR 12,000 NilKeyvan Djamarani PDMR 11,500 NilKevin Burrow PDMR 12,500 NilJenny Owen Company Secretary 10,000 Nil 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise £6.61 22. Total number of shares or debentures over which options held followingnotification Name Status Performance SARS Share Shares Options Mark Throdahl Director 57,000 276,000 462,000Jonathan Glenn Director 49,500 Nil NilPaul Boughton Director 68,000 Nil NilChris Hall PDMR 25,000 42,250 82,000Joe Barry PDMR 24,000 Nil NilKeyvan Djamarani PDMR 34,500 Nil 16,500Kevin Burrow PDMR 12,500 Nil NilJenny Owen Company Secretary 16,000 Nil Nil 23. Any additional information NONE 24. Name of contact and telephone number for queries Jenny OwenCOMPANY SECRETARYTel 01908 525211 Name and signature of duly authorised officer of issuer responsible for makingnotification JENNY OWENDate of notification22 August 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Mar 20201:50 pmRNSTotal Voting Rights
20th Feb 20207:15 amRNSDespatch of formal compulsory acquisition notices
17th Feb 20204:24 pmRNSCompulsory acquisition of Consort Shares
6th Feb 20205:00 pmRNSNotice of Cancellation of Listing
6th Feb 20204:31 pmRNSDirector/PDMR Shareholding
6th Feb 20201:30 pmRNSHolding(s) in Company
5th Feb 20205:30 pmRNSConsort Medical
5th Feb 20204:51 pmRNSHolding(s) in Company
5th Feb 20204:00 pmRNSForm 8.3 - Consort Medical Plc
5th Feb 20203:15 pmBUSFORM 8.3 - CONSORT MEDICAL PLC
5th Feb 202011:42 amBUSForm 8.3 - CONSORT MEDICAL PLC
5th Feb 202011:32 amRNSForm 8.5 (EPT/RI)
5th Feb 20205:00 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
4th Feb 20204:19 pmRNSOffer declared Wholly Unconditional
4th Feb 20203:38 pmBUSForm 8.3 - Consort Medical plc
4th Feb 20203:34 pmRNSForm 8.3 - Consort Medical plc
4th Feb 20203:25 pmBUSForm 8.3 - Consort Medical plc
4th Feb 20203:07 pmRNSForm 8.3 - Consort Medical Plc
4th Feb 20203:00 pmRNSForm 8.3 - Consort Medical Plc
4th Feb 202012:10 pmBUSForm 8.3 - Consort Medical Plc
4th Feb 202011:24 amRNSForm 8.5 (EPT/RI)
4th Feb 202011:08 amRNSForm 8.3 - CONSORT MEDICAL PLC
4th Feb 20209:20 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
4th Feb 20207:25 amBUSForm 8.3 - Consort Medical Plc
3rd Feb 20204:24 pmBUSFORM 8.3 - CONSORT MEDICAL PLC AMENDMENT
3rd Feb 20201:37 pmBUSForm 8.3 - Consort Medical Plc
3rd Feb 202012:43 pmBUSForm 8.3 - CONSORT MEDICAL PLC
3rd Feb 202012:00 pmRNSAdditional Listing
3rd Feb 202010:53 amRNSForm 8.5 (EPT/RI)
3rd Feb 20209:58 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
31st Jan 20205:28 pmRNSForm 8.3 - [Consort Medical plc]
31st Jan 20202:56 pmBUSForm 8.3 - CONSORT MEDICAL PLC
31st Jan 202010:57 amRNSForm 8.5 (EPT/RI)
31st Jan 20209:16 amGNWForm 8.5 (EPT/RI) - Consort Medical Plc
30th Jan 20203:25 pmBUSForm 8.3 - Consort Medical plc
30th Jan 20202:34 pmBUSForm 8.3 - CONSORT MEDICAL PLC
30th Jan 20201:30 pmBUSForm 8.3 - CONSORT MEDICAL PLC
30th Jan 20201:18 pmRNSForm 8.3 - Consort Medical plc
30th Jan 202010:34 amRNSForm 8.5 (EPT/RI)
30th Jan 20209:18 amRNSForm 8.3 - Consort Medical plc
30th Jan 20208:50 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
29th Jan 20204:21 pmRNSHolding(s) in Company
29th Jan 20201:18 pmBUSForm 8.3 - Consort Medical Plc
29th Jan 202011:50 amRNSForm 8.3 - Consort Medical PLC
29th Jan 202011:19 amRNSForm 8.5 (EPT/RI)
29th Jan 202010:41 amRNSResponse to Recipharm Statement
29th Jan 20209:45 amRNSHolding(s) in Company
29th Jan 20207:00 amRNSNo Extension or Increase & Irish CCPC Clearance
28th Jan 20203:25 pmBUSForm 8.3 - Consort Medical plc
28th Jan 20201:59 pmRNSForm 8.3 - Consort Medical Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.